beta

You're viewing our new website - find out more

Publication - Consultation Paper

Prostate cancer clinical quality performance indicators: engagement document

Published: 6 May 2016
ISBN:
9781786522542

Document explaining the process of, and inviting engagement on, revision of the prostate cancer QPIs.

37 page PDF

544.5kB

37 page PDF

544.5kB

Contents
Prostate cancer clinical quality performance indicators: engagement document
12. References

37 page PDF

544.5kB

12. References

1. Scottish Government (2008). Better Cancer Care: An Action Plan [online]. Available from: http://www.scotland.gov.uk/Resource/Doc/242498/0067458.pdf
(accessed August 2013).

2. Scottish Government (2010) Healthcare Quality Strategy for NHSScotland [online]. Available from: http://www.scotland.gov.uk/Resource/Doc/311667/0098354.pdf (accessed August 2013).

3. ACCC (2007) Association of Comprehensive Cancer Centres / Dutch Urological Association. Prostate cancer [online]. Available from: http://www.oncoline.nl/richtlijn/item/pagina.php?richtlijn_id=575
(accessed August 2013).

4. NICE (2008). Prostate cancer: diagnosis and treatment [online]. Available from: http://guidance.nice.org.uk/CG58 (accessed August 2013)

5. PCRMP (2006). Prostate Cancer Risk Management Programme. Undertaking a trans-rectal ultrasound guided biopsy of the prostate [online]. Available from: http://www.cancerscreening.nhs.uk/prostate/pcrmp01.pdf (accessed August 2013).

6. EAU (2010). European Association of Urology. Guidelines on prostate cancer [online]. Available from: http://www.uroweb.org/?id=218&gid=3 (accessed August 2013).

7. Royal College of Radiologists (2007). Making the best use of clinical radiology services (sixth edition) [online].

8. Wang et al (2006). Prediction of Organ-confined Prostate Cancer: Incremental Value of MR Imaging and MR Spectroscopic Imaging to Staging Nomograms. Radiology. 238(2), 597-603.

9. Wang et al (2009). Incremental value of magnetic resonance imaging in the advanced management of prostate cancer. World Journal of Radiology. 1(1), 3-14.

10. Royal College of Pathologists (2009). Dataset for histopathology reports for prostatic carcinoma (2nd edition) [online]. Available from: https://www.rcpath.org/resourceLibrary/dataset-for-histopathology-reports-for-prostatic-carcinoma.html (accessed August 2013).

11. CCO (2008). Cancer Care Ontario. Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: surgical and pathological guidelines [online]. Available from: http://www.cancercare.on.ca/pdf/pebc17-3f.pdf (accessed August 2013).

12. NHS Quality Improvement Scotland (2008). Management of Core Cancer Services Standards [online]. Available from: http://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_resources/standards_for_cancer_services.aspx (accessed August 2013).

13. NICE (2015). Prostate Cancer [online]. Available from: https://www.nice.org.uk/guidance/qs91 (accessed February 2016).

14. Bul et al (2013). Active Surveillance for Low-Risk Prostate Cancer Worldwide:
The PRIAS Study. European Urology. 63 (4), 597 - 603.

15. Nice (2014): Prostate Cancer: Diagnosis and Management. Available from: https://www.nice.org.uk/guidance/cg175 (accessed March 2016)

16. Vickers AJ, Savage CJ, Hruza M, Tuerk I, Koenig P, Martinez-Pineiro L, et al.
The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. Lancet Oncol 2009;10(5):475-80.

17. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al.
The surgical learning curve for prostate cancer control after radical prostatectomy.
J Natl Cancer Inst 2007;99(15):1171-7.

18. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database

19. JB Anderson, NC Clarke, D Gillatt, P Dasgupta, DE Neal,RS Pickard (2012).
Advice on the Development of Robotic Assisted Radical Prostatectomy in England - Prostate Cancer Advisory Group

20. Loblaw, DA, Virgo, KS, Nam, R, Somerfield, MR, Ben-Josef, E, et al. for the American Society of Clinical Oncology (2007). Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology. 25(12), 1596-605.

21. James et all (2015): Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer ( STAMPEDE):survival results from an adaptive, multiarm, multistage,platform randomised controlled trial [online]. Available from www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)01037-5.pdf (Accessed January 2016).

22. NHS Quality Improvement Scotland (2008). Clinical Standards for the Management of Bowel Cancer [online]. Available from: http://www.healthcareimprovementscotland.org/programmes/cancer_care_improvement/cancer_resources/standards_for_cancer_services.aspx
(accessed February 2016).


Contact